Clinical microbiologyAnaerobic bacteraemia: A score predicting mortality
Introduction
Despite all the advances in medical practice in recent years, it is well known that the presence of anaerobes in the bloodstream continues to have a high associated mortality requiring appropriate treatment [1,2]. The detection rate of anaerobes in blood cultures is around 0.5–11.8% of all bacteraemic episodes, depending on geographic location, and both patient age and condition [3]. Some previously reported factors frequently associated with higher mortality from anaerobic bacteraemia include underlying malignancies, especially hematologic, diabetes and gastrointestinal surgery [2,4]. Many of these studies have provided the current understanding of bloodstream anaerobic infections, but difficulties remain in ascertaining the relationship between mortality and both the infection episode itself and the factors that influence prognosis. Thus, there is a need for predictive models of high-risk patients with anaerobic sepsis. The purpose of the present report was to determine those variables which are readily identifiable at the bedside and that are able to predict mortality in patients with bacteraemia caused by anaerobes. Clinical variables, laboratory findings and specific epidemiological factors were analyzed.
Section snippets
Patients
The clinical records of all patients with positive blood cultures for anaerobic microorganisms at the University Hospital Virgen de las Nieves (Granada, Spain) in the period from January 2016 to December 2019 were reviewed retrospectively. This centre is an approximately 700-bed tertiary care institution, serving as a primary facility for nearly 500,000 inhabitants. Blood cultures were performed at the request of the attending physicians, who made the decisions concerning the patient's
Characteristics of patients
The study included 136 cases of bacteraemia from 136 patients, 55% (n = 75) males, with a mean age of 64 years (ranging from 16 to 97). During the period of study, seven patients/cases were excluded due to the presence of polymicrobial infection. The overall incidence of anaerobic bacteraemia was 1.32 episodes/1000 admissions. One hundred and sixteen (85.3%) of episodes were community-acquired and 20 (14.7%) were hospital-acquired. All for whom data were available were treated, although one did
Discussion
Anaerobic bacteraemia accounted for 1.32 episodes per 1000 admissions at this institution from January 2016 to December 2019. This prevalence seems to be similar than that published in previous series [9]. In that report, moreover, the incidence of anaerobic bacteraemia decreased during the period of study. However, other study showed an increasing tendency for anaerobes bloodstream infection (0.26–0.92%) [10].
Mortality from anaerobic bacteraemia has remained high over the past few years.
Funding
None.
Declaration of competing interest
Authors declare no conflict of interest.
References (17)
- et al.
A 62-month retrospective epidemiological survey of anaerobic bacteremia in a university hospital
Clin. Microbiol. Infect.
(2006) - et al.
Anaerobic bacteraemia: a 10-year retrospective epidemiological survey
Anaerobe
(2016) - et al.
Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study
Clin. Microbiol. Infect.
(2005) - et al.
Clinical characteristics associated with mortality of patients with anaerobic bacteremia
Anaerobe
(2016) - et al.
Bloodstream infections in a secondary and tertiary care hospital setting
Intern. Med. J.
(2006) - et al.
Anaerobe-induced bacteremia in Italy: a nationwide survey. The Italian anaerobe study group
Clin. Infect. Dis.
(1995) - et al.
Reemergence of anaerobic bacteremia
Clin. Infect. Dis.
(2007) - et al.
The value of MALDI-TOF MS for the identification of clinically relevant anaerobic bacteria in routine laboratories
J. Med. Microbiol.
(2012)
Cited by (8)
Antibiotic resistance in the commensal human gut microbiota
2022, Current Opinion in MicrobiologyCitation Excerpt :These gut-dwelling, opportunistic pathogens include Clostridioides difficile, Escherichia coli and Enterococcus faecium [8–10]. In addition, species in the genus Bacteroides, in particular Bacteroides fragilis, are among the most prominent anaerobic causes of infection, even though they are widely regarded as commensal members of the gut microbiota [11,12]. Indeed, the human gut microbiota is now recognised as a reservoir of antibiotic resistance determinants, termed the ‘gut resistome’ [13,14].
Infections Caused by Anaerobic Microorganisms
2022, Encyclopedia of Infection and ImmunitySepsis caused by Anaerococcus nagyae after transarterial-chemoembolization for hepatocellular carcinoma: Case report and literature review
2021, AnaerobeCitation Excerpt :A case of bacteremia due to Anaerococcus octavius was reported by Cobo F. et al. [17] The A. octavius strain, isolated in a 71-year-old woman with a history of breast cancer, treated with tumorectomy, local radiotherapy and mitral and aortic insufficiency, was resistant to clindamycin. Two different studies reported various risk factors of mortality for anaerobic bacteremia: hospitalization in an ICU, presence of septic shock and presence of any type of cancer and resistance to clindamycin [18,19]. In our case the strain A. nagyae was also resistant to clindamycin (MIC >256 μg/mL).
Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study
2024, European Journal of Clinical Microbiology and Infectious Diseases